Cargando…
Current progress in searching for clinically useful biomarkers of blood–brain barrier damage following cerebral ischemia
Ischemic stroke is a leading cause of death and disability. Fear of intracranial hemorrhage (ICH) has been the primary reason for withholding tissue plasminogen activator (tPA) and thrombectomy, the only two widely accepted treatments for ischemic stroke. Thrombolysis treatment is only allowed in a...
Autores principales: | Li, Weili, Pan, Rong, Qi, Zhifeng, Liu, Ke Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329218/ https://www.ncbi.nlm.nih.gov/pubmed/30693340 http://dx.doi.org/10.4103/bc.bc_11_18 |
Ejemplares similares
-
Damage to the blood-brain barrier and activation of neuroinflammation by focal cerebral ischemia under hyperglycemic condition
por: Guo, Yongzhen, et al.
Publicado: (2021) -
Blood Occludin Level as a Potential Biomarker for Early Blood Brain Barrier Damage Following Ischemic Stroke
por: Pan, Rong, et al.
Publicado: (2017) -
Inhibition of Src phosphorylation reduces damage to the blood-brain barrier following transient focal cerebral ischemia in rats
por: BAI, YONGSHENG, et al.
Publicado: (2014) -
Dihydrocapsaicin Attenuates Blood Brain Barrier and Cerebral Damage in Focal Cerebral Ischemia/Reperfusion via Oxidative Stress and Inflammatory
por: Janyou, Adchara, et al.
Publicado: (2017) -
Effects of irisin on the dysfunction of blood–brain barrier in rats after focal cerebral ischemia/reperfusion
por: Guo, Peipei, et al.
Publicado: (2019)